Integrated Filing — IndAS


General information about company
Scrip Code 512529
NSE Symbol SEQUENT
MSEI Symbol NA
ISIN INE807F01027
Name of company Sequent Scientific limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 20-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 08-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 20-May-2025   11:00:00
End date and time of board meeting 20-May-2025   12:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-11
Indicate Company website link for updated RPT policy of the Company https://sequent.in/wp-content/uploads/2025/02/5.-Related-Party-Transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 423300000 1782600000
Other income 122700000 509400000
Total income 546000000 2292000000
2 Expenses
(a) Cost of materials consumed 214200000 869100000
(b) Purchases of stock-in-trade 0 102800000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 8700000 83100000
(d) Employee benefit expense 105800000 350500000
(e) Finance costs 9900000 39600000
(f) Depreciation, depletion and amortisation expense 23000000 86700000
(f) Other Expenses
1 Conversion and processing charges 8700000 54000000
2 Other expenses 114100000 436900000
Total other expenses 122800000 490900000
Total expenses 484400000 2022700000
3 Total profit before exceptional items and tax 61600000 269300000
4 Exceptional items -2500000 -48800000
5 Total profit before tax 59100000 220500000
6 Tax expense
7 Current tax 11100000 38800000
8 Deferred tax 5700000 23700000
9 Total tax expenses 16800000 62500000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 42300000 158000000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 42300000 158000000
17 Other comprehensive income net of taxes -1100000 -1500000
18 Total Comprehensive Income for the period 41200000 156500000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 500600000 500600000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 10925900000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.17 0.63
Diluted earnings (loss) per share from continuing operations 0.16 0.62
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.17 0.63
Diluted earnings (loss) per share from continuing and discontinued operations 0.16 0.62
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Please refer BSE website / our website (www.sequent.in) for disclosure of notes on financial results.



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 454700000
Capital work-in-progress 64300000
Investment property 0
Goodwill 0
Other intangible assets 7200000
Intangible assets under development 2200000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 6472500000
Trade receivables, non-current 0
Loans, non-current 3949400000
Other non-current financial assets 30700000
Total non-current financial assets 10452600000
Deferred tax assets (net) 96400000
Other non-current assets 69400000
Total non-current assets 11146800000
2 Current assets
Inventories 250500000
Current financial asset
Current investments 700000
Trade receivables, current 689300000
Cash and cash equivalents 300000
Bank balance other than cash and cash equivalents 3800000
Loans, current 400000
Other current financial assets 10700000
Total current financial assets 705200000
Current tax assets (net)
Other current assets 119500000
Total current assets 1075200000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 12222000000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 500600000
Other equity 10925900000
Total equity attributable to owners of parent 11426500000
Non controlling interest
Total equity 11426500000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 8100000
Total non-current financial liabilities 8100000
Provisions, non-current 23700000
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities 8100000
Total non-current liabilities 39900000
Current liabilities
Current financial liabilities
Borrowings, current 443800000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 96700000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 132600000
Total Trade payable 229300000
Other current financial liabilities 56400000
Total current financial liabilities 729500000
Other current liabilities 19700000
Provisions, current 6400000
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 755600000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 795500000
Total equity and liabilites 12222000000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 (a) Re-measurement gain / (loss) on defined benefits plans -800000 -1700000
2 (b) Fair value gain / (loss) from investment in equity instruments -600000 -400000
Total Amount of items that will not be reclassified to profit and loss -1400000 -2100000
2 Income tax relating to items that will not be reclassified to profit or loss -300000 -600000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -1100000 -1500000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 220500000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 39600000
Adjustments for decrease (increase) in inventories 94900000
Adjustments for decrease (increase) in trade receivables, current -80000000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -95000000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 86700000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -1200000
Adjustments for dividend income 0
Adjustments for interest income 379400000
Adjustments for share-based payments 105100000
Adjustments for fair value losses (gains) -400000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -35100000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -264800000
Net cash flows from (used in) operations -44300000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) -33100000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -11200000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 33300000
Purchase of property, plant and equipment 119100000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 81500000
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 3400000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -3500000
Net cash flows from (used in) investing activities -4400000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 74700000
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 20800000
Payments of lease liabilities 9600000
Dividends paid 0
Interest paid 37700000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 6600000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -9000000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -9000000
Cash and cash equivalents cash flow statement at beginning of period 9300000
Cash and cash equivalents cash flow statement at end of period 300000







Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 SRBC & Co. LLP Yes 28-Feb-2026


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail
Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Sale of goods or services 128790000 NA 128790000 0 0
2 Alivira Animal Health Limited, India Alivira Saude Animal Ltda, Brazil Fellow subsidiary Sale of goods or services 69710000 NA 69710000 0 0
3 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 4550000 NA 4550000 0 0
4 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Sale of goods or services 106150000 NA 106150000 0 0
5 Alivira Animal Health Limited, India Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow subsidiary Sale of goods or services 2360000 NA 2360000 0 0
6 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Fellow subsidiary Sale of goods or services 160000 NA 160000 0 0
7 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Sale of goods or services 160000 NA 160000 0 0
8 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Sale of goods or services 245180000 NA 245180000 0 0
9 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Sale of goods or services 3930000 NA 3930000 0 0
10 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Sale of goods or services 3560000 NA 3560000 0 0
11 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Sale of goods or services 15510000 NA 15510000 0 0
12 Laboratorios Karizoo, S.A., Spain Fendigo SA, Belgium Fellow subsidiary Sale of goods or services 34250000 NA 34250000 0 0
13 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Sale of goods or services 8180000 NA 8180000 0 0
14 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Sale of goods or services 5090000 NA 5090000 0 0
15 Phytotherapic Solutions S.L., Spain Alivira Saude Animal Ltda, Brazil Fellow subsidiary Sale of goods or services 2710000 NA 2710000 0 0
16 Phytotherapic Solutions S.L., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Sale of goods or services 2850000 NA 2850000 0 0
17 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Sale of goods or services 13600000 NA 13600000 0 0
18 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 63190000 NA 63190000 0 0
19 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Fellow subsidiary Sale of goods or services 8080000 NA 8080000 0 0
20 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 3730000 NA 3730000 0 0
21 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Sale of goods or services 204580000 NA 204580000 0 0
22 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Sale of goods or services 259780000 NA 259780000 0 0
23 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Sale of goods or services 87910000 NA 87910000 0 0
24 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Sale of goods or services 12350000 NA 12350000 0 0
25 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Wholly owned subsidiary Sale of goods or services 1570000 NA 1570000 0 0
26 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Purchase of goods or services 3590000 NA 3590000 0 0
27 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Purchase of goods or services 579490000 NA 579490000 0 0
28 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Purchase of goods or services 282860000 NA 282860000 0 0
29 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Purchase of goods or services 530000 NA 530000 0 0
30 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 15510000 NA 15510000 0 0
31 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 5090000 NA 5090000 0 0
32 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, India Fellow subsidiary Purchase of goods or services 71290000 NA 71290000 0 0
33 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Fellow subsidiary Purchase of goods or services 150000 NA 150000 0 0
34 Alivira Saude Animal Ltda, Brazil Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 4400000 NA 4400000 0 0
35 Bremer Pharma GmbH, Germany Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 2850000 NA 2850000 0 0
36 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Purchase of goods or services 245180000 NA 245180000 0 0
37 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Purchase of goods or services 170000 NA 170000 0 0
38 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 34250000 NA 34250000 0 0
39 Laboratorios Karizoo S.A. de C.V.,Mexico Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 15320000 NA 15320000 0 0
40 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Fellow subsidiary Purchase of goods or services 6780000 NA 6780000 0 0
41 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 63190000 NA 63190000 0 0
42 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Purchase of goods or services 3350000 NA 3350000 0 0
43 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 13790000 NA 13790000 0 0
44 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Purchase of goods or services 5220000 NA 5220000 0 0
45 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 5310000 NA 5310000 0 0
46 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Purchase of goods or services 123760000 NA 123760000 0 0
47 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Purchase of goods or services 1800000 NA 1800000 0 0
48 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, India Fellow subsidiary Purchase of goods or services 2650000 NA 2650000 0 0
49 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 430000 NA 430000 0 0
50 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Purchase of goods or services 106230000 NA 106230000 0 0
51 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Interest received 66320000 NA 66320000 0 0
52 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Interest received 70000 NA 70000 0 0
53 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Fellow subsidiary Interest received 22160000 NA 22160000 0 0
54 Alivira Animal Health Limited, Ireland Alivira Saude Animal Brasil Participacoes Ltda Wholly owned subsidiary Interest received 48580000 NA 48580000 0 0
55 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Interest received 11870000 NA 11870000 0 0
56 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Interest received 10020000 NA 10020000 0 0
57 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Interest received 8500000 NA 8500000 0 0
58 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Interest received 1140000 NA 1140000 0 0
59 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Interest received 80000 NA 80000 0 0
60 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Interest received 1880000 NA 1880000 0 0
61 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Interest received 90000 NA 90000 0 0
62 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow subsidiary Interest received 2630000 NA 2630000 0 0
63 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Interest received 191620000 NA 191620000 0 0
64 Vila Vina Participacions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Subsidiary Interest received 10000 NA 10000 0 0
65 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Interest received 2490000 NA 2490000 0 0
66 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow subsidiary Interest paid 2630000 NA 2630000 0 0
67 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Interest paid 376070000 NA 376070000 0 0
68 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Interest paid 125510000 NA 125510000 0 0
69 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Interest paid 1120000 NA 1120000 0 0
70 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Subsidiary Interest paid 100000 NA 100000 0 0
71 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Interest paid 1790000 NA 1790000 0 0
72 Alivira Animal Health Limited, Ireland Vila Vina Participacions S.L., Spain Subsidiary Interest paid 220000 NA 220000 0 0
73 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Interest paid 70000 NA 70000 0 0
74 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Fellow subsidiary Interest paid 17060000 NA 17060000 0 0
75 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Interest paid 51280000 NA 51280000 0 0
76 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Interest paid 12050000 NA 12050000 0 0
77 Laboratorios Karizoo S.A. de C.V.,Mexico Vila Vina Participacions S.L., Spain Holding Interest paid 20000 NA 20000 0 0
78 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Interest paid 90000 NA 90000 0 0
79 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Interest paid 2490000 NA 2490000 0 0
80 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Interest paid 12210000 NA 12210000 0 0
81 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Ultimate Holding company Interest paid 9720000 NA 9720000 0 0
82 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Dividend received 202470000 NA 202470000 0 0
83 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Dividend received 8800000 NA 8800000 0 0
84 Alivira Saude Animal Brasil Participacoes Ltda Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Wholly owned subsidiary Dividend received 24520000 NA 24520000 0 0
85 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Dividend received 40000 NA 40000 0 0
86 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Advertisement and selling expenses 7550000 NA 7550000 0 0
87 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Advertisement and selling expenses 540000 NA 540000 0 0
88 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Advertisement and selling expenses 5290000 NA 5290000 0 0
89 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow subsidiary Any other transaction Analytical charges 56890000 NA 56890000 0 0
90 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Analytical charges 5170000 NA 5170000 0 0
91 Fendigo SA, Belgium Fendigo BV, Netherland Fellow subsidiary Any other transaction Commission expenses 61970000 NA 61970000 0 0
92 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Commission expenses 100000 NA 100000 0 0
93 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Commission expenses 2000000 NA 2000000 0 0
94 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction cost of sales 76490000 NA 76490000 0 0
95 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction cost of sales 3320000 NA 3320000 0 0
96 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction cost of sales 61360000 NA 61360000 0 0
97 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Freight and forwarding 5900000 NA 5900000 0 0
98 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Freight and forwarding 2750000 NA 2750000 0 0
99 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Gurantee commission 3860000 NA 3860000 0 0
100 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Miscellaneous Income 35570000 NA 35570000 0 0
101 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow subsidiary Any other transaction Miscellaneous Income 1570000 NA 1570000 0 0
102 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Miscellaneous Income 47130000 NA 47130000 0 0
103 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Miscellaneous Income 7260000 NA 7260000 0 0
104 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Miscellaneous Income 6590000 NA 6590000 0 0
105 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Miscellaneous Income 970000 NA 970000 0 0
106 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Miscellaneous Income 3990000 NA 3990000 0 0
107 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Miscellaneous Income 100000 NA 100000 0 0
108 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Miscellaneous Income 9550000 NA 9550000 0 0
109 Fendigo SA, Belgium Fendigo BV, Netherland Fellow subsidiary Any other transaction Miscellaneous Income 10490000 NA 10490000 0 0
110 Fendigo SA, Belgium Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Miscellaneous Income 750000 NA 750000 0 0
111 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Miscellaneous Income 61970000 NA 61970000 0 0
112 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Miscellaneous Income 170000 NA 170000 0 0
113 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Miscellaneous Income 14160000 NA 14160000 0 0
114 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Miscellaneous Income 1550000 NA 1550000 0 0
115 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Miscellaneous Income 7070000 NA 7070000 0 0
116 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Miscellaneous Income 670000 NA 670000 0 0
117 Laboratorios Karizoo, S.A., Spain Fendigo SA, Belgium Fellow subsidiary Any other transaction Miscellaneous Income 3360000 NA 3360000 0 0
118 Laboratorios Karizoo, S.A., Spain Fendigo BV, Netherland Fellow subsidiary Any other transaction Miscellaneous Income 50000 NA 50000 0 0
119 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Subsidiary Any other transaction Miscellaneous Income 13350000 NA 13350000 0 0
120 Laboratorios Karizoo, S.A., Spain N-Vet AB, Sweden Fellow subsidiary Any other transaction Miscellaneous Income 610000 NA 610000 0 0
121 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Miscellaneous Income 25770000 NA 25770000 0 0
122 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Miscellaneous Income 3700000 NA 3700000 0 0
123 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Miscellaneous Income 270000 NA 270000 0 0
124 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Miscellaneous Income 270000 NA 270000 0 0
125 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Miscellaneous Income 30000 NA 30000 0 0
126 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Miscellaneous Income 14350000 NA 14350000 0 0
127 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Miscellaneous Income 35240000 NA 35240000 0 0
128 Sequent Research Limited, India Sequent Scientific Limited, India Holding Any other transaction Miscellaneous Income 9260000 NA 9260000 0 0
129 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Miscellaneous Income 75580000 NA 75580000 0 0
130 Sequent Scientific Limited, India Alivira Animal Health Limited, Ireland Step down subsidiary Any other transaction Miscellaneous Income 4810000 NA 4810000 0 0
131 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Miscellaneous Income 420000 NA 420000 0 0
132 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Miscellaneous Income 3320000 NA 3320000 0 0
133 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction other boorrowing cost 22680000 NA 22680000 0 0
134 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction other boorrowing cost 2540000 NA 2540000 0 0
135 Alivira Animal Health Limited, Ireland Sequent Scientific Limited, India Ultimate Holding company Any other transaction other boorrowing cost 4860000 NA 4860000 0 0
136 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, India Fellow subsidiary Any other transaction other boorrowing cost 350000 NA 350000 0 0
137 Sequent Research Limited, India Sequent Scientific Limited, India Holding Any other transaction other boorrowing cost 40000 NA 40000 0 0
138 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction other boorrowing cost 4120000 NA 4120000 0 0
139 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 170000 NA 170000 0 0
140 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Other Expenses 1590000 NA 1590000 0 0
141 Fendigo BV, Netherland Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 50000 NA 50000 0 0
142 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Holding Any other transaction Other Expenses 200000 NA 200000 0 0
143 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Other Expenses 440000 NA 440000 0 0
144 Phytotherapic Solutions S.L., Spain Fendigo SA, Belgium Fellow subsidiary Any other transaction Other Expenses 750000 NA 750000 0 0
145 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 250000 NA 250000 0 0
146 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction other income 8750000 NA 8750000 0 0
147 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Any other transaction other income 790000 NA 790000 0 0
148 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Professional fees 3280000 NA 3280000 0 0
149 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Professional fees 46390000 NA 46390000 0 0
150 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Professional fees 17930000 NA 17930000 0 0
151 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Professional fees 13920000 NA 13920000 0 0
152 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 6680000 NA 6680000 0 0
153 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 1550000 NA 1550000 0 0
154 Alivira Saude Animal Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 7140000 NA 7140000 0 0
155 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 1000000 NA 1000000 0 0
156 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 670000 NA 670000 0 0
157 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 3360000 NA 3360000 0 0
158 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Professional fees 3000000 NA 3000000 0 0
159 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Holding Any other transaction Professional fees 13330000 NA 13330000 0 0
160 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Professional fees 9250000 NA 9250000 0 0
161 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Professional fees 270000 NA 270000 0 0
162 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Professional fees 1000000 NA 1000000 0 0
163 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Professional fees 10450000 NA 10450000 0 0
164 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 590000 NA 590000 0 0
165 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 2740000 NA 2740000 0 0
166 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Professional fees 1350000 NA 1350000 0 0
167 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 4240000 NA 4240000 0 0
168 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 4380000 NA 4380000 0 0
169 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Professional fees 21690000 NA 21690000 0 0
170 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Rent 10850000 NA 10850000 0 0
171 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Rent 560000 NA 560000 0 0
172 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Rent 270000 NA 270000 0 0
173 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Any other transaction Rent 270000 NA 270000 0 0
174 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Research & Development expenses 2470000 NA 2470000 0 0
175 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Research & Development expenses 22030000 NA 22030000 0 0
176 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Support service charges 570000 NA 570000 0 0
177 Sequent Research Limited, India Sequent Scientific Limited, India Holding Any other transaction Support service charges 1300000 NA 1300000 0 0
178 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Travel expenses 800000 NA 800000 0 0
179 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Travel expenses 8760000 NA 8760000 0 0
180 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Advances from customers 0 NA 0 86890000 162910000
181 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Borrowing 0 NA 0 1145120000 1235840000
182 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Any other transaction Borrowing 0 NA 0 46910000 47260000
183 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Subsidiary Any other transaction Borrowing 0 NA 0 9790000 11710000
184 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Any other transaction Borrowing 0 NA 0 58080000 106780000
185 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Fellow subsidiary Any other transaction Borrowing 0 NA 0 384140000 410950000
186 Alivira Saude Animal Brasil Participacoes Ltda Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Wholly owned subsidiary Any other transaction Borrowing 0 NA 0 770000 0
187 Alivira Animal Health UK Limited Alivira Animal Health Limited, Ireland Holding Any other transaction Borrowing 0 NA 0 2460000 2880000
188 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Borrowing 0 NA 0 1068780000 1091680000
189 Laboratorios Karizoo S.A. de C.V.,Mexico Vila Vina Participacions S.L., Spain Holding Any other transaction Borrowing 0 NA 0 1960000 100000
190 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Borrowing 0 NA 0 525070000 544780000
191 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Borrowing 0 NA 0 0 148160000
192 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Borrowing 0 NA 0 226530000 238930000
193 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 1145120000 1235840000
194 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 9160000 9110000
195 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Loans and Advances 0 NA 0 383700000 409000000
196 Alivira Animal Health Limited, Ireland Alivira Saude Animal Brasil Participacoes Ltda Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 953620000 1023180000
197 Alivira Animal Health Limited, Ireland Alivira Animal Health UK Limited Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 2300000 2790000
198 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 1071180000 1093680000
199 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 527030000 172860000
200 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Any other transaction Loans and Advances 0 NA 0 226890000 240340000
201 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Loans and Advances 0 NA 0 86890000 162910000
202 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Brasil Participacoes Ltda Holding Any other transaction Loans and Advances 0 NA 0 770000 0
203 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances 0 NA 0 46790000 46380000
204 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances 0 NA 0 9310000 9220000
205 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Loans and Advances 0 NA 0 57920000 106520000
206 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Loans and Advances 0 NA 0 30930000 17280000
207 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Loans and Advances 0 NA 0 19270000 18070000
208 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 3815150000 3967710000
209 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 1550000 0
210 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Loans and Advances 0 NA 0 0 148160000
211 Vila Vina Participacions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Subsidiary Any other transaction Loans and Advances 0 NA 0 1960000 100000
212 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Any other transaction Loans and Advances 0 NA 0 94670000 74240000
213 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow subsidiary Any other transaction Borrowing 0 NA 0 19270000 18070000
214 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Borrowing 0 NA 0 3776980000 3949430000
215 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Borrowing 0 NA 0 9130000 9090000
216 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Any other transaction Borrowing 0 NA 0 952860000 1028130000
217 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Borrowing 0 NA 0 30930000 17280000
218 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Borrowing 0 NA 0 94670000 74240000
219 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Purchase/sale of PPE 0 NA 0 0 6970000
220 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Purchase/sale of PPE 0 NA 0 0 6070000
221 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Payable 0 NA 0 3650000 3840000
222 Alivira Animal Health Limited, India Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Payable 0 NA 0 1630000 320000
223 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 130000 180000
224 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable 0 NA 0 3530000 1560000
225 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow subsidiary Any other transaction Trade Payable 0 NA 0 12010000 21430000
226 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Trade Payable 0 NA 0 326890000 492820000
227 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Trade Payable 0 NA 0 35200000 67820000
228 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Trade Payable 0 NA 0 0 2220000
229 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Payable 0 NA 0 16630000 9950000
230 Alivira Animal Health Limited, Ireland Sequent Scientific Limited, India Ultimate Holding company Any other transaction Trade Payable 0 NA 0 0 1340000
231 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0 NA 0 51350000 55180000
232 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 33620000 38620000
233 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 2990000 2850000
234 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Trade Payable 0 NA 0 20090000 39090000
235 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Fellow subsidiary Any other transaction Trade Payable 0 NA 0 0 150000
236 Alivira Saude Animal Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 440000 840000
237 Alivira Saude Animal Ltda, Brazil Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 1510000 0
238 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Trade Payable 0 NA 0 25180000 1750000
239 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Trade Payable 0 NA 0 2580000 0
240 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0 NA 0 46890000 47300000
241 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 6950000 7550000
242 Bremer Pharma GmbH, Germany Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 980000 3860000
243 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable 0 NA 0 910000 900000
244 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Payable 0 NA 0 50000 1060000
245 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0 NA 0 2230000 0
246 Fendigo SA, Belgium Fendigo BV, Netherland Fellow subsidiary Any other transaction Trade Payable 0 NA 0 9780000 6180000
247 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 520000 4140000
248 Fendigo SA, Belgium Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 0 120000
249 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Trade Payable 0 NA 0 1720000 3110000
250 Fendigo BV, Netherland Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 50000 0
251 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Holding Any other transaction Trade Payable 0 NA 0 8360000 12020000
252 Laboratorios Karizoo S.A. de C.V.,Mexico Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 24170000 30040000
253 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Trade Payable 0 NA 0 2260000 2300000
254 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Trade Payable 0 NA 0 5360000 6060000
255 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Payable 0 NA 0 20000 20000
256 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 14710000 23350000
257 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable 0 NA 0 1040000 3300000
258 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 1430000 100000
259 N-Vet AB, Sweden Sequent Scientific Limited, India Ultimate Holding company Any other transaction Trade Payable 0 NA 0 0 810000
260 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Payable 0 NA 0 1060000 370000
261 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 6980000 4310000
262 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0 NA 0 142430000 121660000
263 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Payable 0 NA 0 26440000 36060000
264 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 57950000 8400000
265 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Trade Payable 0 NA 0 151160000 0
266 Sequent Scientific Limited, India N-Vet AB, Sweden Step down subsidiary Any other transaction Trade Payable 0 NA 0 0 7500000
267 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Trade Payable 0 NA 0 2650000 2520000
268 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0 NA 0 810000 800000
269 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Receivable 0 NA 0 35370000 69130000
270 Alivira Animal Health Limited, India Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 20150000 39380000
271 Alivira Animal Health Limited, India Alivira Saude Animal Brasil Participacoes Ltda Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 24320000 1710000
272 Alivira Animal Health Limited, India Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 3390000 0
273 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 2260000 2320000
274 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Trade Receivable 0 NA 0 4240000 3850000
275 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Trade Receivable 0 NA 0 49400000 54740000
276 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 0 160000
277 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Trade Receivable 0 NA 0 40890000 42740000
278 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction Trade Receivable 0 NA 0 2150000 0
279 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Receivable 0 NA 0 5220000 5970000
280 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Trade Receivable 0 NA 0 154130000 138580000
281 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 20000 20000
282 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 1060000 370000
283 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 50000 1060000
284 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 1340000 330000
285 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable 0 NA 0 0 2220000
286 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 26570000 36350000
287 Fendigo SA, Belgium Fendigo BV, Netherland Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 1720000 3110000
288 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 9780000 6180000
289 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 140000 180000
290 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Trade Receivable 0 NA 0 17130000 10240000
291 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 33620000 38620000
292 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 440000 840000
293 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 6950000 7550000
294 Laboratorios Karizoo, S.A., Spain Fendigo SA, Belgium Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 520000 4140000
295 Laboratorios Karizoo, S.A., Spain Fendigo BV, Netherland Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 50000 0
296 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Subsidiary Any other transaction Trade Receivable 0 NA 0 8360000 12040000
297 Laboratorios Karizoo, S.A., Spain N-Vet AB, Sweden Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 1440000 100000
298 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 6980000 4310000
299 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 58240000 8470000
300 Laboratorios Karizoo, S.A., Spain Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 820000 810000
301 N-Vet AB, Sweden Sequent Scientific Limited, India Ultimate Holding company Any other transaction Trade Receivable 0 NA 0 0 7660000
302 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 2990000 2850000
303 Phytotherapic Solutions S.L., Spain Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 1520000 0
304 Phytotherapic Solutions S.L., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 980000 3860000
305 Phytotherapic Solutions S.L., Spain Fendigo SA, Belgium Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 0 120000
306 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 24170000 31100000
307 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 14710000 23350000
308 Alivira Animal Health Limited, India Rajaram Narayanan Managing Director Remuneration 6250000 NA 6250000 0 0
309 Alivira Animal Health Limited, India Nihar Ranjan Das Company Secretary Remuneration 1140000 NA 1140000 0 0
310 Alivira Animal Health Limited, India Vedprakash Ragate Executive Director Remuneration 6820000 NA 6820000 0 0
311 Sequent Scientific Limited, India Rajaram Narayanan Managing Director Remuneration 10860000 NA 10860000 0 0
312 Sequent Scientific Limited, India Saurav Bhala Chief Financial Officer Any other transaction Salary 7220000 NA 7220000 0 0
313 Sequent Scientific Limited, India Phillip Trott Company Secretary Any other transaction Salary 1260000 NA 1260000 0 0
314 Sequent Scientific Limited, India Dr Kamal Sharma Independent Directors Any other transaction Director sitting Fees 2400000 NA 2400000 0 0
315 Sequent Scientific Limited, India Milind Sarwate Independent Directors Any other transaction Director sitting Fees 2700000 NA 2700000 0 0
316 Sequent Scientific Limited, India Revati Kasture Independent Directors Any other transaction Director sitting Fees 400000 NA 400000 0 0
317 Sequent Scientific Limited, India Fabian Kausche Non- Executive Directors Any other transaction Director sitting Fees 700000 NA 700000 0 0
318 Sequent Scientific Limited, India Gregory Andrews Non- Executive Directors Any other transaction Director sitting Fees 800000 NA 800000 0 0
319 Sequent Scientific Limited, India Dr. Hari Babu Non- Executive Directors Any other transaction Director sitting Fees 600000 NA 600000 0 0
320 Sequent Scientific Limited, India Yoshita Susmit Vora Company Secretary Any other transaction Salary 910000 NA 910000 0 0
321 Sequent Scientific Limited, India Dr. Kausalya Santhanam Independent Directors Any other transaction Director sitting Fees 1300000 NA 1300000 0 0
322 Sequent Scientific Limited, India Dr Kamal Sharma Independent Directors Any other transaction Director commission 1000000 NA 1000000 0 1000000
323 Sequent Scientific Limited, India Milind Sarwate Independent Directors Any other transaction Director commission 1300000 NA 1300000 0 1300000
324 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiaries Any other transaction Additional / (reduction) of guarantee given 400000000 NA 400000000 1336820000 1736820000
325 Sequent Scientific Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiaries Any other transaction Additional / (reduction) of guarantee given 543730000 NA 543730000 1938130000 2481860000
326 Sequent Scientific Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Rent paid 110000 NA 110000 0 0
327 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiaries Any other transaction Additional / (reduction) of guarantee received during the year (net) 0 NA 0 380000000 380000000
328 Alivira Animal Health Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Purchase of fixed assets 300000 NA 300000 0 0
329 Alivira Animal Health Limited, India Symed Labs Limited Other related party Any other transaction Purchase of fixed assets 720000 NA 720000 0 0
330 Alivira Animal Health Limited, India Symed Labs Limited Other related party Any other transaction Trade Payable 0 NA 0 5750000 7490000
331 Alivira Animal Health Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Trade Payable 0 NA 0 0 2470000
332 Sequent Research Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Rent paid 1110000 NA 1110000 0 0
333 Sequent Research Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Trade Payable 0 NA 0 0 200000
334 Alivira Animal Health Limited, India Symed Labs Limited Other related party Purchase of goods or services 23020000 NA 23020000 0 0
335 Alivira Animal Health Limited, India Viyash Life Sciences Private Limited Other related party Purchase of goods or services 2170000 NA 2170000 0 0
336 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 3500000 3520000
337 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 910000 890000
338 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 1030000 3280000
339 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow subsidiary Any other transaction Trade Receivable 0 NA 0 12010000 21430000
340 Sequent Research Limited, India Sequent Scientific Limited, India Holding Any other transaction Trade Receivable 0 NA 0 2650000 2520000
341 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Receivable 0 NA 0 326890000 492820000
342 Sequent Scientific Limited, India Alivira Animal Health Limited, Ireland Step down subsidiary Any other transaction Trade Receivable 0 NA 0 4040000 1340000
343 Sequent Scientific Limited, India N-Vet AB, Sweden Step down subsidiary Any other transaction Trade Receivable 0 NA 0 0 800000
344 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Trade Receivable 0 NA 0 151160000 0
345 Sequent Scientific Limited, India Dr. Kausalya Santhanam Independent Directors Any other transaction Director commission 300000 NA 300000 0 300000
346 Alivira Animal Health USA LLC Fabian Kausche Non- Executive Directors Any other transaction Professional fees 1800000 NA 1800000 0 0
347 Fendigo SA, Belgium Gregory Andrews Non- Executive Directors Any other transaction Professional fees 1690000 NA 1690000 0 0
Total value of transaction during the reporting period 6080260000





Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt